View in EDS

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies.

Saved in:
Bibliographic Details
Title: In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies.
Authors: Ieranò C; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Righelli D; Statistical Sciences, University of Padua, Padua, Italy., D'Alterio C; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Napolitano M; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Portella L; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Rea G; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Auletta F; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Santagata S; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Trotta AM; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Guardascione G; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Liotti F; Institute of Endocrinology and Experimental Oncology (IEOS), CNR-NA1, Napoli, Italy., Prevete N; Institute of Endocrinology and Experimental Oncology (IEOS), CNR-NA1, Napoli, Italy.; Traslational Medical Sciences, University of Naples Federico II, Napoli, Italy., Maiolino P; Pharmacy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Luciano A; Animal Facility, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Barbieri A; Animal Facility, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Di Mauro A; Pathology, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Roma C; Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Esposito Abate R; Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Tatangelo F; Pathology, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Pacelli R; Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy., Normanno N; Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy., Melillo RM; Institute of Endocrinology and Experimental Oncology (IEOS), CNR-NA1, Napoli, Italy.; Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Napoli, Italy., Scala S; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy s.scala@istitutotumori.na.it.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Mar; Vol. 10 (3).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35246475
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ieranò+C%22">Ieranò C</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Righelli+D%22">Righelli D</searchLink>; Statistical Sciences, University of Padua, Padua, Italy.<br /><searchLink fieldCode="AU" term="%22D'Alterio+C%22">D'Alterio C</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Napolitano+M%22">Napolitano M</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Portella+L%22">Portella L</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Rea+G%22">Rea G</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Auletta+F%22">Auletta F</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Santagata+S%22">Santagata S</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Trotta+AM%22">Trotta AM</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Guardascione+G%22">Guardascione G</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Liotti+F%22">Liotti F</searchLink>; Institute of Endocrinology and Experimental Oncology (IEOS), CNR-NA1, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Prevete+N%22">Prevete N</searchLink>; Institute of Endocrinology and Experimental Oncology (IEOS), CNR-NA1, Napoli, Italy.; Traslational Medical Sciences, University of Naples Federico II, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Maiolino+P%22">Maiolino P</searchLink>; Pharmacy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Luciano+A%22">Luciano A</searchLink>; Animal Facility, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Barbieri+A%22">Barbieri A</searchLink>; Animal Facility, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Di+Mauro+A%22">Di Mauro A</searchLink>; Pathology, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Roma+C%22">Roma C</searchLink>; Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Esposito+Abate+R%22">Esposito Abate R</searchLink>; Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Tatangelo+F%22">Tatangelo F</searchLink>; Pathology, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Pacelli+R%22">Pacelli R</searchLink>; Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Normanno+N%22">Normanno N</searchLink>; Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Melillo+RM%22">Melillo RM</searchLink>; Institute of Endocrinology and Experimental Oncology (IEOS), CNR-NA1, Napoli, Italy.; Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Scala+S%22">Scala S</searchLink>; Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy s.scala@istitutotumori.na.it.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2022 Mar; Vol. 10 (3).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35246475
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2021-004032
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ieranò C
      – PersonEntity:
          Name:
            NameFull: Righelli D
      – PersonEntity:
          Name:
            NameFull: D'Alterio C
      – PersonEntity:
          Name:
            NameFull: Napolitano M
      – PersonEntity:
          Name:
            NameFull: Portella L
      – PersonEntity:
          Name:
            NameFull: Rea G
      – PersonEntity:
          Name:
            NameFull: Auletta F
      – PersonEntity:
          Name:
            NameFull: Santagata S
      – PersonEntity:
          Name:
            NameFull: Trotta AM
      – PersonEntity:
          Name:
            NameFull: Guardascione G
      – PersonEntity:
          Name:
            NameFull: Liotti F
      – PersonEntity:
          Name:
            NameFull: Prevete N
      – PersonEntity:
          Name:
            NameFull: Maiolino P
      – PersonEntity:
          Name:
            NameFull: Luciano A
      – PersonEntity:
          Name:
            NameFull: Barbieri A
      – PersonEntity:
          Name:
            NameFull: Di Mauro A
      – PersonEntity:
          Name:
            NameFull: Roma C
      – PersonEntity:
          Name:
            NameFull: Esposito Abate R
      – PersonEntity:
          Name:
            NameFull: Tatangelo F
      – PersonEntity:
          Name:
            NameFull: Pacelli R
      – PersonEntity:
          Name:
            NameFull: Normanno N
      – PersonEntity:
          Name:
            NameFull: Melillo RM
      – PersonEntity:
          Name:
            NameFull: Scala S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2022 Mar
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1